BDL Consulting assist in developing Disruptive Diabetes CGM Technology

For the past three years BDL.consulting have been working with Californian based Medtech Start Up called Metronom Health Inc. Metronom Health is developing a cutting edge Opto-enzymatic technology sensor capable of accurately sensing the Glucose levels in a Diabetic patients blood. The Continuous Glucose Monitoring Device (CGM) has an inbuilt sensor that sends light signals to a chemistry based sensor. The chemistry is under the patients skin and in the blood flow where it sense the oxygen filled blood colour. The light signal is returned to the sensor where it is converted to electronic signal and fed to the Device wearer's Smart Watch or Smart Phone via a Bluetooth signal where an App converts the signal via algorithms to display the current blood glucose levels to the patient according to the set frequency. This technology removes the need for the patient too 'prick' their finger 8 times a day to get the same reading from glucose strips and readers. The device can be worn for 14 days and is currently more accurate than any of its current market competitors.
BDL consulting designed and developed the mechanical wearable device and applicator with the Metronomhealth team, hired the relative support engineers, brought in 3D printer systems for the early prototyping and even supported the implementation of Greenlight Guru eQMS software. We also set up an internal Design department utilising CREO CAD software supported by Windchill PLM systems from PTC and set up the ASME engineering design standards, procedures and protocols to comply with the DHF for FDA submission. All in all a very busy and fulfilling project.

www.metronomhealth.com

Device video
https://vimeo.com/258946867/d6e68c04ad

Screenshot 2019-10-04 16.07.15